Amneal Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) €2.95B +8.4% €314.50M +24.1% 10.7% +0.013 pp €429.02M +62.4% 14.5% +0.048 pp
    (estimated) €2.72B +6.4% €253.45M +20.9% 9.3% +0.011 pp €264.14M -4.3% 9.7% -0.011 pp
    (estimated) €2.56B +7.3% €209.72M -310.4% 8.2% +0.12 pp €275.91M -6.8% 10.8% -0.016 pp
    €2.38B +16.7% -€99.70M +39.2% -4.2% -0.0067 pp €295.99M -16.3% 12.4% -0.049 pp
    €2.04B +8.2% -€71.64M -35.4% -3.5% +0.024 pp €353.78M +166.4% 17.3% +0.10 pp
    €1.89B +5.7% -€110.87M -1,323.5% -5.9% -0.064 pp €132.80M -47.1% 7.0% -0.070 pp
    €1.79B +5.1% €9.06M -88.3% 0.5% -0.041 pp €251.16M -33.9% 14.1% -0.083 pp
    €1.70B +22.5% €77.67M -115.1% 4.6% +0.42 pp €379.72M +349.1% 22.3% +0.16 pp
    €1.39B -2.2% -€514.82M +255.6% -37.1% -0.27 pp €84.56M -71.5% 6.1% -0.15 pp
    €1.42B +60.9% -€144.77M -201.2% -10.2% -0.26 pp €296.25M -0.3% 20.9% -0.13 pp
    €881.66M +1.5% €143.00M -19.2% 16.2% -0.041 pp €297.22M +45.4% 33.7% +0.10 pp
    €868.50M +17.5% €176.88M +22.4% 20.4% +0.0081 pp €204.42M +7.8% 23.5% -0.021 pp
    €738.89M €144.53M 19.6% €189.58M 25.7%

    Notifications